Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Hypersensitivity × 30 days × Clear all

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Glioma 9 Glioblastoma 7 Breast Neoplasms 7 Prostatic Neoplasms 6 Neoplasms 5 Sarcoma 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Melanoma 3 Lung Neoplasms 3 Leukemia 3 Brain Neoplasms 3 Triple Negative Breast Neoplasms 2 Ovarian Neoplasms 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Diffuse Intrinsic Pontine Glioma 2 Colorectal Neoplasms 2 Colorectal Cancer Metastatic 2 Colonic Neoplasms 2 Uterine Cervical Dysplasia 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Small Cell Lung Carcinoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07420036 2026-03-03

SFB6-ZN01 PET

Zhongnan Hospital

Phase EARLY_PHASE1 Not yet recruiting

Hypersensitivity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡